Matthew Stanley, D.O., vice president, behavioral health clinical service line, Avera Health (South Dakota) is the 2023 chair of AHA’s Committee on Behavioral Health. Jill Howard, R.N., assistant vice president, behavioral health, Lifepoint Health (Tennessee), will serve as the 2023 chair-elect, and Arpan Waghray, M.D., CEO, Well-Being Trust (Washington) will serve as the 2023 past-chair. 
 
Joining the committee as members are Nathaniel Clark, M.D., chief medical officer and behavioral health chief of staff, Vanderbilt University Medical Center (Tennessee); Beth Heinz, service line executive, mental health and addiction services, M Health Fairview (Minnesota); Garrett Hoover, president and chief operating officer, Carroll Hospital and senior vice president, LifeBridge Health (Maryland); Tracey Lavallias, executive director, behavioral health service line, Lancaster General Health (Pennsylvania); Tamara Player, CEO, Polara Health (Arizona);and Jesse Tamplen, vice president, behavioral health services, John Muir Health (California).

The committee advises AHA on policy and advocacy, and provides a forum for strategic discussion of issues important to behavioral health providers and the field. For more information on AHA’s work on behavioral health, click here.
 

Headline
Duke University School of Medicine’s Jonathan Posner, M.D., professor of psychiatry and behavioral sciences, and Matthew Engelhard, M.D., Ph.D., assistant…
Headline
Elinore Kaufman, M.D., medical director of the Penn Trauma Violence Recovery Program, and Michele Volpe, chief operating officer of the University of…
Chairperson's File
Behavioral health is a crucial component of overall health and well-being, and we see the need and demand for behavioral health care services increasing for…
Headline
In this conversation, three leaders from CommonSpirit Health explore how the organization is confronting stigma about substance use head-on through education,…
Perspective
Public
May is Mental Health Awareness Month, a time to elevate a conversation that hospitals and health systems live every day. Behavioral health is inseparable from…
Headline
The Food and Drug Administration today announced it is accelerating regulatory action on a new class of psychedelic-based therapies, following an April 18…